Naturo Indiabull (543579)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Operates in the personal care industry, which has long-term demand potential in India.
• Small market cap of ₹26 Cr leaves room for a genuine operational turnaround to create outsized returns.
• The stock has attracted speculative buying interest, rising from ₹2.17 to ₹14.00 over the 52-week range.
• Latest quarterly net loss is near zero in absolute rupee terms, suggesting minimal ongoing cash burn.

Concerns

• Sales growth is -100% and latest quarter revenue is ₹0 Cr, meaning the core business is generating no income.
• ROCE is -2.50% and profit growth is -140.82%, showing destruction of value rather than compounding.
• Piotroski F-Score of 2/9 indicates very weak financial health.
• Critical fundamental data — book value, ROE, debt/equity, promoter holding — is unavailable, preventing any margin-of-safety calculation.

AI Analysis

Let me be blunt: there is nothing here for the rational investor to analyze. Naturo Indiabull trades at ₹14 with a market cap of ₹26 crore, yet the latest quarter shows zero sales and a net loss. Sales growth of -100% means the business, as currently operating, has no revenue. The return on capital employed is -2.50%, and the Piotroski F-Score is a miserable 2 out of 9, indicating poor financial health. I cannot calculate book value, return on equity, or debt-to-equity from the data provided, and that itself is a red flag. In Graham's framework, the first requirement is numbers you can trust; without a positive earnings record or a stated book value, the stock has no margin of safety. The only notable fact is the share price has risen from ₹2.17 to ₹14, but price action is not evidence of intrinsic value. A business with zero sales and negative profits cannot justify a ₹26 crore market cap based on fundamentals. The personal care industry can produce excellent franchises, but this company has yet to show it can generate any revenue. There is no dividend, no promoter holding disclosure, and negative growth. This looks like a speculative shell, not a growing enterprise. I would need years of consistent profitability, clear return on equity, and honest disclosure before I would even put this on a watchlist. As Buffett says, it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Here, we do not even know if it is a company in the economic sense. This is a pass.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer